​

Aquestive Therapeutics Ownership | Who Owns Aquestive Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Aquestive Therapeutics Ownership Summary

Aquestive Therapeutics is owned by 58.93% institutional investors, 3.05% insiders, and 38.01% retail investors. Bratton capital management is the largest institutional shareholder, holding 8.00% of AQST shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.71% of its assets in Aquestive Therapeutics shares.

AQST Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAquestive Therapeutics58.93%3.05%38.01%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustrySpecialty & Generic Drug Manufacturers Stocks37.12%13.99%48.89%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bratton capital management9.81M8.00%$40.81M
Blackrock5.45M7.41%$14.18M
Blackrock funding, inc. /de8.07M6.58%$33.57M
Rtw investments, lp7.43M6.06%$30.89M
Vanguard group5.89M5.33%$38.06M
Vanguard capital management4.58M3.74%$19.07M
Federated hermes3.11M2.54%$12.95M
State street2.93M2.39%$12.18M
Geode capital management2.62M2.14%$10.91M
Samsara biocapital2.50M2.04%$10.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bratton capital management9.81M100.00%$40.81M
Propel bio management1.44M3.14%$6.00M
Everstar asset management611.94K1.23%$2.55M
Sio capital management1.49M1.02%$6.18M
Samsara biocapital2.50M0.85%$10.40M
Latash investments243.13K0.74%$1.01M
Blue owl capital lp942.93K0.59%$3.92M
Dafna capital management645.91K0.51%$2.69M
Harvey capital management343.75K0.41%$1.92M
Rosalind advisors250.00K0.39%$1.04M

Top Buyers

HolderShares% AssetsChange
Blackrock5.45M0.00%4.11M
Nuveen1.22M0.00%961.76K
Propel bio management1.44M3.14%731.41K
Blackrock funding, inc. /de8.07M0.00%560.30K
Wasatch advisors lp1.39M0.04%507.53K

Top Sellers

HolderShares% AssetsChange
Vr adviser---2.63M
Ecor1 capital---2.63M
Balyasny asset management744.54K0.00%-2.16M
Franklin resources---2.13M
Bioimpact capital---1.61M

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company306.39K0.00%306.39K$1.27M
Gsa capital partners llp116.26K0.03%116.26K$484.00K
Longaeva partners71.02K0.06%71.02K$396.97K
Virtu financial69.58K0.01%69.58K$289.00K
Beacon pointe advisors60.50K0.00%60.50K$251.07K

Sold Out

HolderChange
National bank of canada /fi/-4.00
Northwestern mutual wealth management-4.00
Mai capital management-5.00
Coppell advisory solutions-16.00
Highmark wealth management-50.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261933.21%72,257,2360.33%581.71%97-8.49%43-8.51%
Mar 31, 202686-54.50%13,538,137-81.25%110.26%48-60.33%18-51.35%
Dec 31, 2025116-26.58%37,857,717-42.70%340.77%76-27.62%22-24.14%
Sep 30, 202515036.36%65,817,25445.31%663.19%9848.48%2833.33%
Jun 30, 2025118-5.60%47,569,6177.50%472.23%66-9.59%26-13.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.40M2.71%108.80K
Vanguard Morn Total Stk Mkt Idx Investor3.40M2.71%108.80K
Vanguard MStar Total Stk Mkt Idx Invest3.40M2.71%-
Vanguard US Total Market Shares ETF2.40M2.43%-
iShares Russell 2000 ETF2.87M2.28%24.48K
Federated Hermes MDT SCC Institutional1.39M1.11%-
Federated Hermes MDT Small Cap Core IS1.39M1.11%-
State Street® SPDR® S&P® PhrmctlsETF1.33M1.06%-
Fidelity Small Cap Index1.17M0.93%2.92K
Vanguard Institutional Extnd Mkt Idx Tr1.08M0.86%2.46K

Recent Insider Transactions

DateNameRoleActivityValue
Sep 15, 2026Barber Daniel President and CEOSell$120.49K
Sep 09, 2026Korczynski Sherry Chief Commercial OfficerSell$45.67K
Aug 17, 2026Barber Daniel President and CEOSell$107.17K
Jul 15, 2026Barber Daniel President and CEOSell$18.68K
Jul 16, 2026Barber Daniel President and CEOSell$81.51K

Insider Transactions Trends

DateBuySell
2026 Q3-5
2026 Q2-3
2026 Q1-7
2025 Q4-3
2025 Q3-5

AQST Ownership FAQ

Who Owns Aquestive Therapeutics?

Aquestive Therapeutics shareholders are primarily institutional investors at 58.93%, followed by 3.05% insiders and 38.02% retail investors. The average institutional ownership in Aquestive Therapeutics's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.12%, which Aquestive Therapeutics exceeds.

Who owns the most shares of Aquestive Therapeutics?

Aquestive Therapeutics’s largest shareholders are Bratton capital management (9.81M shares, 8.00%), Blackrock (5.45M shares, 7.41%), and Blackrock funding, inc. /de (8.07M shares, 6.58%). Together, they hold 21.99% of Aquestive Therapeutics’s total shares outstanding.

Does Blackrock own Aquestive Therapeutics?

Yes, BlackRock owns 7.41% of Aquestive Therapeutics, totaling 5.45M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.18M$. In the last quarter, BlackRock increased its holdings by 4.11M shares, a 305.59% change.

Who is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested?

Bratton capital management is Aquestive Therapeutics’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 9.81M Aquestive Therapeutics shares, valued at 40.81M$.

Who is the top mutual fund holder of Aquestive Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aquestive Therapeutics shares, with 2.71% of its total shares outstanding invested in 3.4M Aquestive Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools